MAGEB2 is a cancer-testis antigen and Type I MAGE family protein with multifaceted roles in cell proliferation and stress response. Primary function: MAGEB2 enhances cell proliferation through E2F transcription factor activation by interacting with and inhibiting HDAC1 1, while also promoting ribosome biogenesis through interaction with phospho-UBF to increase rRNA transcription 2. Mechanistically, MAGEB2 functions as an RNA-binding protein that suppresses stress granule formation by translational repression of G3BP, thereby enhancing cellular stress tolerance in testicular tissues 3. Additionally, MAGEB2 mediates degradation of EGR1 to regulate spermatogonial stem cell proliferation and apoptosis 4, and suppresses TGFβ1 signaling by decreasing TSP-1 mRNA levels 5. Disease relevance: MAGEB2 is aberrantly expressed in multiple cancers including laryngeal cancer, where elevated expression correlates with increased cell invasion, lymphatic metastasis, and reduced CD8+ T cell infiltration 6. Expression occurs through epigenetic demethylation of its promoter in malignant peripheral nerve sheath tumors 7 and is regulated by JunD transcription factor 5. Clinical significance: MAGEB2 expression represents a prognostic marker in laryngeal cancer and could guide immunotherapy strategies, while its role in spermatogenesis suggests potential therapeutic targets for male fertility disorders.